Answers are grounded in this paper and cite their sources.
In this issue, Birnbaum and colleagues evaluate whether the availability of efficient adjuvant and chemotherapy treatments would have changed reductions in the risk for breast cancer death reported by randomized trials on breast cancer screening. The editorialist discusses these results and the implications for women having breast cancer screening.
No takes yet. Share an insight, caveat, or question.
Philippe Autier (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: